|Bid||127.85 x 1100|
|Ask||130.14 x 800|
|Day's Range||125.38 - 129.81|
|52 Week Range||117.64 - 169.98|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 03, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||199.33|
Subscribe to Yahoo Finance Plus to view Fair Value for JAZZ
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present seven abstracts from across its neuroscience portfolio at the 35th annual Psych Congress 2022, being held September 17-20, 2022.
All three of these cannabis-related stocks turned profits last quarter and have had strong revenue growth.
In this article, we discuss the top 10 stock picks of Henrik Rhenman’s Rhenman Partners. You can skip our comprehensive analysis of Rhenman Partners’ history, investment philosophy, and hedge fund performance and go directly to Top 5 Stock Picks of Henrik Rhenman’s Rhenman Partners. Founded by American biochemist and billionaire Henrik Rhenman in 2008, Rhenman […]